CRP and non-Hodgkin lymphoma: According to Zhu et al., C-reactive protein (CRP) may serve as a potential biomarker for site-specific cancer risk assessment, including head and neck, esophagus, stomach, colorectal, liver, kidney, breast, lung, and non-Hodgkin lymphomas.